Psoriasis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Anti-Inflammatory Effects of 0.045% Tazarotene/0.01% Halobetasol Lotion in Psoriasis
Condition:   Psoriasis Vulgaris Interventions:   Drug: 0.01% Halobetasol;   Drug: 0.045% Tazarotene;   Drug: 0.05% Clobetasol Propionate Sponsor:   Dermatology Consulting Services, PLLC Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials

Study of Guselkumab Versus Placebo for the Treatment of Low Body Surface Area Moderate Plaque Psoriasis
Condition:   Moderate Plaque Psoriasis Interventions:   Drug: Guselkumab;   Drug: Placebo Sponsor:   Janssen Research & Development, LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2023 Category: Research Source Type: clinical trials